Inventor · disambiguated record
Joshua Backman
Also filed as: BACKMAN JOSHUA
5 granted patents·12 pending applications·2 citations·filing 2018–2024
64Inventor score
Top patents by PatentIndex Score
17 records- 0187US11584966B2Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereofREGENERON PHARMA·Filed 2020·Granted Feb 21, 2023·2 cites·8 claims
- 0278US2025122574A1Piezo Type Mechanosensitive Ion Channel Component 1 (PIEZO1) Variants And Uses ThereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0375US12163192B2Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereofREGENERON PHARMA·Filed 2023·Granted Dec 10, 2024·0 cites·9 claims
- 0474US2025170226A1Methods Of Treating Skin Cancer With Histidine Ammonia-Lyase (HAL) AgonistsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0566US12186378B2Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonistsREGENERON PHARMA·Filed 2022·Granted Jan 7, 2025·0 cites·10 claims
- 0661US2024207204A1Treatment Of Type 2 Diabetes With Hepatocyte Nuclear Factor 4 Alpha (HNF4A) AgonistsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0760US2023025878A1Methods Of Treating A Metabolic Disorder With Mitogen-Activated Protein Kinase Kinase Kinase 15 (MAP3K15) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0860US2023041060A1Treatment of Varicose Veins With Piezo Type Mechanosensitive Ion Channel Component 1 (PIEZO1) AgonistsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0959US2021230609A1Solute Carrier Family 14 Member 1 (SLC14A1) Variants And Uses ThereofREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1057US2023074721A1Treatment Of Inflammatory Diseases With RAS Protein Activator Like 3 (RASAL3) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1156US2023107173A1Methods Of Treating Chronic Kidney Disease (CKD) With Inhibitors Of Protective Loss-Of-Function GenesREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1256US2023023182A1Methods Of Treating Asthma With Solute Carrier Family 27 Member 3 (SLC27A3) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1355US2023027007A1Treatment of Hypertension With Solute Carrier Family 9 Isoform A3 Regulatory Factor 2 (SLC9A3R2) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1455US2019071683A1Solute Carrier Family 14 Member 1 (SLC14A1) Variants And Uses ThereofREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 1552US11453235B2Chalk line marking deviceBACKMAN JOSHUA·Filed 2020·Granted Sep 27, 2022·0 cites·9 claims
- 1646US2020263251A1Matrix Extracellular Phosphoglycoprotein (MEPE) Variants And Uses ThereofREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 1721USD982464SChalk line marking deviceBACKMAN JOSHUA·Filed 2021·Granted Apr 4, 2023·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Joshua Backman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →